Recurrence rates and relapse-free survival for patients with completely resected melanoma: Contemporary experience.

e22080Background: An estimated 100,000 new diagnoses of malignant melanoma are expected in 2020. Systemic treatment with immune checkpoint inhibitors (ICIs) and targeted therapy with BRAF/MEK inhib...